Extracorporeal Membrane Oxygenation Market Expected to Reach $952.2 Million by 2035

According to a new report published by Allied Market Research, titled, “Extracorporeal Membrane Oxygenation Market," The extracorporeal membrane oxygenation market was valued at $527.52 million in 2023, and is estimated to reach $952.2 million by 2035, growing at a CAGR of 5% from 2024 to 2035.

The extracorporeal membrane oxygenation market growth is driven by rise in prevalence of respiratory and cardiac disorders, advancements in ECMO technology, and rise in adoption of these systems in critical care settings. The growing incidence of conditions such as acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), and cardiogenic shock has significantly increased the demand for ECMO as a life-saving intervention.

For instance, according to the American Lung Association, in 2022, 11.7 million people, or 4.6% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease, chronic bronchitis, or emphysema. In addition, rise in technological advancements, such as development of portable and more efficient ECMO systems, has enhanced patient outcomes and expanded the scope of ECMO applications which is expected to drive the extracorporeal membrane oxygenation market growth. 

However, the market faces restraints, including high cost of ECMO procedures and equipment, limited availability of specialized healthcare professionals, and complications associated with prolonged ECMO use, such as infections and bleeding risks. In addition, stringent regulatory requirements and reimbursement challenges also pose barriers to market adoption, particularly in developing regions. On the other hand, advancements in ECMO technology, increase in prevalence of respiratory and cardiac disorders, and expanding applications in critical care present opportunities for the growth of the extracorporeal membrane oxygenation market opportunity.

The extracorporeal membrane oxygenation market analysis is segmented into component, modulation, application, patient type, and region. By component, the market is segregated into controllers, pumps, oxygenator, cannula, and accessories. The oxygenator segment dominated the extracorporeal membrane oxygenation market share in 2023 and is expected to register the highest CAGR during the forecast period. This is attributed to its critical role in oxygenating blood and removing carbondioxide during ECMO procedures. Rise in incidence of severe respiratory and cardiac conditions, such as acute respiratory distress syndrome (ARDS) and cardiogenic shock, has significantly driven the demand for efficient oxygenators.

On the basis of modulation, the market is classified into veno arterial, veno venous, and others. The veno arterial segment accounted for the largest extracorporeal membrane oxygenation market share in 2023 and is expected to register the highest CAGR during the forecast period, owing to its critical role in providing cardiac and respiratory support for patients with severe cardiac failure. Increase in adoption in cases of cardiogenic shock, cardiac arrest, and post-cardiotomy support contributed to its dominance. In addition, advancements in VA-ECMO technology and rise in use in emergency and intensive care settings further drive the segment growth.

On the basis of application, the market is classified into cardiac diseases, respiratory disorders, and extracorporeal cardiopulmonary resuscitation. The respiratory disorders segment accounted for the largest extracorporeal membrane oxygenation market size in 2023 and is expected to register the highest CAGR during the forecast period, owing to rise in prevalence of severe respiratory conditions such as ARDS, pneumonia, -related complications. Increased adoption of ECMO for managing respiratory failure, along with advancements in oxygenation technology, contributed to segment dominance. Growing awareness and improved accessibility to ECMO in critical care further supported the market growth.

On the basis of patient type, the market is categorized into neonates, pediatric, and adult. The adult segment accounted for the largest extracorporeal membrane oxygenation market size in 2023 and is expected to register the highest CAGR during the forecast period. This is attributed to rise in incidence of respiratory and cardiac disorders among adults. Increased utilization of ECMO in treating conditions such as ARDS, cardiogenic shock, and post-cardiotomy support drive the segment growth.

Region-wise, North America dominated the extracorporeal membrane oxygenation market share in 2023, owing to presence of advanced healthcare infrastructure, high adoption of ECMO in critical care, and a strong focus on research and development. Rise in prevalence of respiratory and cardiac disorders, along with favorable reimbursement policies and increasing ECMO centers, further contributed to the region’s market leadership.

However, Asia-Pacific is anticipated to witness notable growth during the forecast period owing to rise in prevalence of respiratory and cardiac diseases, improving healthcare infrastructure, and increase in awareness of advanced life support technologies. Growing investments in critical care facilities, expanding ECMO programs, and surge in medical tourism further contribute to the region’s rapid market expansion, and are also the extracorporeal membrane oxygenation market trends.

Key Findings of the Study

• On the basis of component, the oxygenator segment dominated the global market in 2023 and is expected to register the highest CAGR during the forecast period.
• On the basis of modulation, the veno arterial segment dominated the extracorporeal membrane oxygenation industry in 2023 and is anticipated to be the fastest-growing segment during the forecast period.
• On the basis of application, the respiratory disorders segment dominated the market in terms of revenue in 2023 and is expected to register the highest CAGR during the extracorporeal membrane oxygenation market forecast period.
• On the basis of patient type, the adult segment dominated the extracorporeal membrane oxygenation industry in terms of revenue in 2023 and is anticipated to be the fastest-growing segment during the forecast period.  
• Region-wise, North America dominated the market in terms of revenue in 2023. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.